As Chair of the Perks Private Wealth Investment Committee, Christo overseas the investment decisions which drive much of our client investment advice. He is also a driving force in the Perks Family Office.
Christo Hall is the Chair of the Perks Private Wealth Investment Committee. With over 30 years’ experience and an impressive track record of investment management across both public and private markets in the APAC region, Christo is a driving force in the Perks Family Office.
In the role of Chair of the Perks Private Wealth Investment Committee, Christo oversees the investment decisions which drive much of our client investment advice. His strong connections on the Eastern seaboard, and across the globe, enhances Perks Private Wealth’s ongoing search for the best investment opportunities.
Over the course of his career, Christo has been involved with some of the biggest names in investment, including Goldman Sachs JBWere, Argo Investments, BlackRock, and Ellerston Capital.
Christo is well known in South Australia for the instrumental role he played as Senior Portfolio Manager at Argo Investments during a very successful period between 2003 and 2014.
While at BlackRock, Christo was based in Hong Kong, where he helped oversee the $35 billion Asian Fundamental Equities Team and was also co-head of research for the Fundamental Equity Division. Over the course of his career, Christo has had significant exposure to a wide range of markets and investment opportunities beyond typical asset classes, including Private Equity, co-investments, and early IPO funding.
More recently, Christo acted as the Chief Investment Officer (CIO) of leading Australian investment manager Ellerston Capital in Sydney, which was founded by the Packer family in 2002 and now has more than $4 billion in funds under management. While at Ellerston, Christo also served as Chair of the Environmental, Social, and Governance (ESG) Committee.
Back home in Adelaide, Christo has now transitioned to Board roles, holding non-executive director positions at Funds SA and AMP Superannuation Limited. He is also Chairman of BiomeBank, a private South Australian biomedical company.